• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Titan Pharmaceuticals, Inc. - Common Stock (NQ:TTNP)

    4.610 UNCHANGED
    Streaming Delayed Price Updated: 3:19 PM EDT, Oct 1, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 4.610
    Bid (Size) 5.910 (5)
    Ask (Size) 5.980 (2)
    Prev. Close 4.610
    Today's Range 4.610 - 4.610
    52wk Range 3.030 - 5.760
    Shares Outstanding 1,330,234
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Curious about the stocks that are showing activity after the closing bell on Friday?
    Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session. 
    Via Chartmill
    Black Titan Corporation (BTTC) Plummets 58.30% Amidst Post-Merger Volatility
    New York, NY – October 3, 2025 – Black Titan Corporation (NYSE: BTTC) witnessed a dramatic 58.30% decline in its stock price today, a sharp reversal after an astonishing nearly 300% surge just... 
    Via MarketMinute
    Topics Intellectual Property Supply Chain

    Performance

    YTD
    +44.5%
    +44.5%
    1 Month
    +9.8%
    +9.8%
    3 Month
    +3.6%
    +3.6%
    6 Month
    +24.3%
    +24.3%
    1 Year
    -13.4%
    -13.4%

    More News

    Read More
    Thursday's after hours session: top gainers and losers
    Via Chartmill
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Titan Pharmaceuticals Stock Surges 23% After Hours on Stockholder Approval of Three-Way Merger
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SCS, HLVX, BSGM, TTNP on Behalf of Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP
    From Kahn Swick & Foti, LLC
    Via Business Wire
    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS, VBTX, TTNP on Behalf of Shareholders July 31, 2025
    From Halper Sadeh LLC
    Via GlobeNewswire
    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CARM, ENZB, HSON, TTNP on Behalf of Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    US Stocks Likely To Open Higher: Expert Says 'The Selling Pressure Is Starting To Be Exhausted'
    Via Benzinga
    Goldman Sachs, M&T Bank And 3 Stocks To Watch Heading Into Monday
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITI, TTNP, FRZA on Behalf of Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Iteris, Inc. (Nasdaq - ITI), Forza X1, Inc. (Nasdaq - FRZA), Titan Pharmaceuticals, Inc. (Nasdaq - TTNP), Gatos Silver, Inc. (NYSE - GATO)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CFB, SDIG, TTNP on Behalf of Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BALY, K, TTNP on Behalf of Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP
    From Kahn Swick & Foti, LLC
    Via Business Wire

    Frequently Asked Questions

    Is Titan Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Titan Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Titan Pharmaceuticals, Inc. - Common Stock trade on?
    Titan Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Titan Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Titan Pharmaceuticals, Inc. - Common Stock is TTNP on the Nasdaq Stock Market
    What is the current price of Titan Pharmaceuticals, Inc. - Common Stock?
    The current price of Titan Pharmaceuticals, Inc. - Common Stock is 4.610
    When was Titan Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Titan Pharmaceuticals, Inc. - Common Stock was at 10/01/25 03:19 PM ET
    What is the market capitalization of Titan Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Titan Pharmaceuticals, Inc. - Common Stock is 6.13M
    How many shares of Titan Pharmaceuticals, Inc. - Common Stock are outstanding?
    Titan Pharmaceuticals, Inc. - Common Stock has 6M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.